Purdue Opioid Deal May Be Worth Less Than Drugmaker Promised September 20, 2019 By Erik Larson and Jef Feeley Purdue Pharma LP’s deal to escape thousands of lawsuits over its role in the U.S. opioid crisis may provide less...
